E

EyePoint Pharmaceuticals
D

EYPT

7.31100
USD
0.19
(2.68%)
مغلق
حجم التداول
22,850
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
503,079,831
أصول ذات صلة
ABBV
ABBV
5.160
(2.67%)
198.440 USD
AMGN
AMGN
-2.15
(-0.76%)
281.20 USD
BMY
BMY
1.000
(2.02%)
50.560 USD
CVS
CVS
-1.965
(-2.83%)
67.465 USD
GE
GE
4.155
(2.04%)
207.695 USD
HCA
HCA
5.17
(1.51%)
348.09 USD
IBM
IBM
5.850
(2.44%)
245.440 USD
LLY
LLY
10.33
(1.27%)
823.96 USD
UNH
UNH
-0.99
(-0.25%)
399.26 USD
المزيد
الأخبار المقالات

العنوان: EyePoint Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.